Researchers to study impact of cord blood stem cells on autism
Could cord blood help children with autism?
The FDA has approved a new study to find out.
Sutter Neuroscience Institute and CBR (Cord Blood Registry) are launching a clinical trial to see if a child’s own cord blood stem cells can help ease certain symptoms of autism.
The study will enroll 30 children between the ages of two and seven. Over the course of 13 months, participants will receive two infusions, one of the child’s own cord blood stem cells and one of a placebo. The participants and the researchers will not know which infusion contains the actual stem cells.
The children will be then evaluated to see if the therapy leads to measurable improvements in language and behavior.
To learn more about the study, click here.
To find out more about the clinical trial, click here.